Workflow
Aquestive(AQST) - 2024 Q2 - Quarterly Results
AQSTAquestive(AQST)2024-08-06 20:24

Exhibit 99.1 Aquestive Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update • Late-stage pipeline program, Anaphylm™ (epinephrine) Sublingual Film, remains on track for a near-term New Drug Application (NDA) submission to the FDA • Expanded sales coverage for Libervant™ (diazepam) Buccal Film for patients between ages two to five with national retail distribution anticipated in the fourth quarter 2024 • Anticipates holding epinephrine prodrug technology investor day in the ...